Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

85 results found in London

Sort by:
Showing 1 - 10 of 85 results
Oncology
Offers video consultation
Recommended by 3 specialists
18 years of experience
Bile Duct Cancer (Cholangiocarcinoma), Biliary Cancer, Bowel Cancer + 10more

Dr Daniel Krell is a Consultant Oncologist, specialising in gastro-oesophageal, colorectal, pancreatic, liver and bile duct cancers and neuroendocrine tumours. He is experienced in using chemotherapy, targeted therapy and immunotherapy. Dr Krell also manages patients with cancer of unknown primary and is the clinical lead for this. He works as a member of the multidisciplinary team for gastro-oesophageal and hepatobiliary cancer at the Royal Free Trust. He is also the clinical lead for Neuroendocrine tumour oncology at The Royal Free Hospital.

He undertook oncology training at University College and the Royal Free Hospitals in London. In addition to his primary medical degree, he also gained a Bachelor’s degree in immunology and microbiology, in addition to a DPhil in Clinical Medicine at the University of Oxford’s Wellcome Trust Centre for Human Genetics and was funded by Cancer Research UK and HCA. His research involved the design of models to investigate the role that genetic mutations in genes controlling cellular metabolism play in the development of cancer. This may help identify new therapeutic targets in this area. Dr Krell continues to be involved in clinical research and trials aimed at identifying new cancer therapies, focused on gastrointestinal, hepatobiliary and neuroendocrine tumours. He has published a number of peer-reviewed papers and presented at national and international conferences.

Diseases, Medical Tests and Treatments

  • Chemotherapy
  • Immunotherapy
  • Biological Therapy
  • Genetic Testing
  • Liver Cancer
  • Biliary Cancer
  • Bowel Cancer
  • Colorectal Cancer
  • Oesophageal Cancer
  • Pancreatic Cancer


Read more
Oncology
23 years of experience
Lung Cancer, Medical Oncology, Mesothelioma + 1more

Dr Thomas Newsom-Davis a Consultant Medical Oncologist at Chelsea and Westminster Hospital. He specialises in thoracic malignancies, especially lung cancer and mesothelioma. In 2015, he was awarded the Macmillan Innovation Excellence Award.

Training

Dr Newsom-Davis completed his training at University College and Middlesex School of Medicine, London, in 1998, including First Class honours for his BSc. He went on specialise in medical oncology at Charing Cross and Hammersmith Hospitals and completed a PhD in tumour immunology. He was appointed to Chelsea & Westminster Hospital in 2010.

Current Roles

Dr Newsom-Davis leads the lung cancer service for Chelsea & Westminster Hospital, and is Vice Chair of the British Thoracic Oncology Group (BTOG) Steering Committee, an organistion which supports and educates thoracic oncology profressionals across the United Kingdom. Dr Newsom-Davis is Chair of the Harley Street Clinic lung cancer multidisciplinary team (MDT), and Chair of the HCA Healthcare UK Thoracic Oncology Board.

Research

Dr Newsom-Davis has an active clinical trial portfolio, and has presented his work at National and International meetings. He has been an invited lecturer for organisations including the Royal College of Physicians, European Society of Medical Oncology, International Association for the Study of Lung Cancer, British Medical Association and the Association of Cancer Physicians.


Diseases, Medical Tests and Treatments

  • Immunotherapy, Targeted Therapy, Chemotherapy
  • Lung Cancer
  • Mesothelioma

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Read more
Oncology
Recommended by 2 specialists
28 years of experience
Clinical Oncology, Medical Oncology

Dr Mary McCormack is a Consultant Clinical Oncologist, specialising in gynaecological andf breast cancers. She qualified in medicine from Guy's and St Thomas' Hospital. Before medical school, she undertook research in radiation biology and was awarded a PhD in 1989. Dr McCormack has worked in leading London cancer centres and in 2000, she was awarded the FRCR in clinical oncology. She was appointed a consultant at University College London Hospital in 2002.

Dr McCormack treats all subtypes of gynaecological cancer, including ovary, womb, uterus, cervix, vulva, vagina and also treats breast cancer. Treatments include chemotherapy, targeted/ biological therapy,radiotherapy and brachytherapy. She has a particular interest in cervical cancer treatment and targeted agents in breast, ovarian and endometrial cancer. Dr McCormack is a major contributor to national and international clinical trials and is the chief investigator on a nuber of studies. She is the current chair of the international Cervical Cancer Research Network (CCRN)and an exective member of the Gynaecologic Cancer Intergroup (GCIG)and a member of the International Gynaecologic Cancer Society's education committee.She is also a member of the ASCO International Affairs Committee.

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.


Diseases, Medical Tests and Treatments
  • Radiotherapy
  • Chemotherapy
  • Brachytherapy
  • Cervical Cancer
  • Breast Cancer
  • Gynaecological Cancers
  • uterine cancer
  • vaginal and vulval cancer
  • ovary cancer
  • chemotherapy 
  • biological therapy
  • radiotherapy
Read more

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Read more

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Read more

Dr Charalampia Kyriakou is a Consultant Haematologist at University College London Hospitals NHS Trust (UCLH), London North West University Healthcare NHS Trust (LNWH) and the Royal National Orthopaedic Hospital Myeloma Spinal Service. She also prides a first-class service with HCA Healthcare, where she helps patients suffering from multiple myeloma, lymphoma and other blood cancers. She also specialises in stem cell transplantation for multiple, lymphoma and for patients with multiple sclerosis.

She offers a holistic approach to treatments, with her patients best interest at heart at all times. She is dedicated to improving outcomes and wellbeing for her patients.

After qualifying with a Medical Degree, she completed an extensive rotational training scheme in haematology at University College London Hospital before being appointed as Consultant. Since then she has been appointed to numerous committees and teams, including the stem cell transplantation team for Myeloma at UCLH, the Myeloma Spinal Service at RNOH and is the Lead for Myeloma and Lymphoma services at LNWH.

She is heavily involved in national and international clinical trials with a passion for improving cancer outcomes. During her career, she has published over 50 peer-reviewed papers and contributed to two chapters in haematology textbooks.


Diseases, Medical Tests and Treatments
  • Chemotherapy for haematological blood cancer conditions
  • Stem Cell Transplantation for Myeloma, Lymphoma and Multiple Sclerosis
  • Multiple Myeloma paraproteinemias
  • Lymphoma (Non-Hodgkin's and Hodgkin's Lymphoma)
  • Transplation for Myeloma and Lymphoma
Read more
Oncology
22 years of experience
Clinical Oncology, Medical Oncology

Professor Tobias Arkenau is a renowned Consultant Medical Oncologist with HCA Healthcare at numerous locations including Sarah Cannon Research Institute, The Harley Street Clinic, The Princess Grace and The Wellington Hospital. Additionally, he holds an NHS post at University College London Hospital where he is a Professorial Research Associate.

He is a founding Medical Director of the Sarah Cannon Research Institute UK and is currently serving as the Executive Medical Director for SCRI UK and Clinical Lead for the HCA Healthcare UK Cancer Service Line. The talented physician has a wide range of experience in a variety of cancers, particularly gastrointestinal and skin cancers.

He was awarded his medical degree from Hanover Medical School in Germany in 2000. Following this, he completed his specialist training in oncology across numerous centres of excellence including the Royal Marsden Hospital. He was awarded a Fellowship by the Royal College of Physicians, and he is a key opinion leader in his field of Gastrointestinal Cancers, Drug Development and Immunotherapy for his reserach contributions to his field. During his career, he has published numerous peer reviewed articals and book chapters and contributes regulalry at international meetings such as ASCO, ESMO and AACR. He is leading the Sarah Cannon Institute UK as a Chief and Principal Investigator of numerous clinical trials of new anti-cancer drugs including immunotherapies and cellular therapies.

Diseases, Medical Tests and Treatments

  • Immunotherapy
  • Chemotherapy
  • Clinical Trials, Phase-1 studies
  • Drug Development, Experimental Therapies
  • TIL-Therapy
  • Biological Therapy
  • Video Consultation
  • Genetic Testing (Genomics Review Board)
  • Gastrointestinal Cancer
  • Skin Cancer
  • Upper Gastrointestinal Cancer
  • Lower Gastrointestinal Cancer
  • Melanoma
  • Bile Duct Cancer
  • Bowel Cancer
  • Colon Cancer
  • Gallbladder Cancer
  • Liver Cancer
  • Oesophagus Cancer
  • Pancreatic Cancer
  • Stomach Cancer
  • Small Bowel Cancer
Read more
Oncology
Offers video consultation
Recommended by 1 specialist
29 years of experience
Brain Cancer, Medical Oncology, Neuro-Oncology

Dr Mulholland is a medical Oncologist who exclusively treats brain cancer at University College Hospital, the National Hospital for Neurology and Neurosurgery (part of UCLH) and Mount Vernon Cancer Centre.He is also an honorary senior lecturer at UCL and a training programme director. 

His doctoral research was in genomic profiling in brain cancer at Cancer Research UK - this has led to his focus on developing biomarkers and targets for therapy in brain cancer, including the clinical trial portfolio of novel agents in brain cancer which he now runs at UCLH and nationally. 

He is a clinical lead in a European Consortium called Datrix, a multidisciplinary European collaboration to advance next-generation targeted hyperthermic cancer treatment for glioblastoma.

 

 

 


Diseases, Medical Tests and Treatments

  • Cancer prevention and screening 
  • Chemotherapy 
  • Brain cancer 
  • Neuro-endocrine tumours 
  • Central nervous system cancer 
  • Novel agents 


Read more
Oncology
30 years of experience
Bowel Cancer, Gastrointestinal Cancers, Oesophageal Cancer + 6more

Dr Amen Sibtain is a Consultant Clinical Oncologist specialising in the management of Gastrointestinal, Hepatobiliary and Head and Neck cancers with chemotherapy and radiotherapy. He is also highly experienced in chemo-radiotherapy, state of the art radiotherapy techniques, including VMAT, stereotactic radiotherapy and radiosurgery, and intraoperative radiotherapy.

Dr Sibtain was previously President of the Oncology Section of the Royal Society of Medicine, Programme Director for Clinical Oncology Specialist Training Committee for the London Deanery and Chairman of the Head and Neck Tumour Board for North East London. He was awarded an MD degree for his research in tumour hypoxia by the University of London.

As well as his clinical work he remains actively involved in research. He has been published in a number of peer-reviewed journals and edited the books Towards the Prevention of Cancer (2007) and Physics for Clinical Oncologists (2012).

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Read more
Oncology
Offers video consultation
20 years of experience
Lung Cancer, Clinical Oncology, Breast Cancer + 4more

Dr. John Conibear completed his initial medical training at the University Hospital of Wales in 2001 and completed his post-graduate general medical training in The Barts and The London Training rotation in 2006. Before gaining his substantive post as a consultant clinical oncologist in St. Bartholomew’s Hospital in 2014, he completed a 2-year fellowship with the NCRI Radiotherapy Trials Quality Assurance Group in Mount Vernon Hospital. During his fellowship, he conducted research into techniques to improve clinician target outlining during radiotherapy planning and was subsequently awarded an MD(Res) from UCL in 2018.

Dr. Conibear is currently deputy medical director and deputy director of Barts Cancer Centre. Dr Conibear specialises in all the non-surgical treatments for both lung and breast cancers. He has expertise in chemotherapy, biological therapy, immunotherapy, radiotherapy and state of the art radiotherapy techniques including deep inspiration breath-hold (DIBH) for early breast cancer, Intensity Modulated Radiotherapy (IMRT), Image-Guided Radiotherapy (IGRT), 4D-CT and both Cyberknife and Gamma Knife (stereotactic radiotherapy). He is also currently the lead for chemotherapy and clinical director for thoracic oncology in St. Bartholomew’s Hospital in addition to his private practice.


Diseases, Medical Tests and Treatments

  • Chemotherapy
  • Deep Inspiration Breath Hold
  • Gamma Knife
  • Image-guided radiotherapy (IGRT)
  • Immunotherapy
  • Intensity modulated radiotherapy (IMRT)
  • Radiotherapy
  • Breast cancer
  • Lung cancer


Read more